Sheffield to market Wockhardt's recombinant insulin in cell culture sector
This article was originally published in Scrip
Executive Summary
Wockhardt and Sheffield Bio-Science of the US have entered into an alliance under which Sheffield will exclusively sell and distribute the Indian firm's recombinant insulin into the worldwide cell culture market.